Oxyresveratrol (CAS 29700-22-9) Ultimate Guide
Contents
- Product Overview & Specifications
- Applications & Industrial Uses
- Usage Guidelines
- Case Studies
- Client Success Stories
- Request Customized Solution
1. Product Overview & Specifications
| Parameter | Oxyresveratrol | Standard Resveratrol |
|---|---|---|
| CAS Number | 29700-22-9 | 501-36-0 |
| Purity | 98%-99.5% | 95%-98% |
| Molecular Formula | C14H12O4 | C14H12O3 |
| Melting Point | 210-215°C | 253-255°C |
| Bioavailability | 3.2x Higher | Baseline |
2. Key Applications
Pharmaceutical Applications
• Neuroprotective agent in Alzheimer’s research
• Anti-inflammatory compound in arthritis formulations
Cosmeceutical Uses
• Tyrosinase inhibitor in whitening creams (IC50 52.3μM)
• Antioxidant in anti-aging serums (ORAC 28,000 μTE/g)
3. Usage Guidelines
| Application | Recommended Concentration | Synergistic Compounds |
|---|---|---|
| Skincare Products | 0.5%-2% | Vitamin C, Ferulic Acid |
| Nutraceuticals | 50-200mg/day | Piperine, Quercetin |
4. Implementation Case Studies
Case 1: Anti-Aging Serum Development
Korean beauty brand achieved 37% improvement in wrinkle depth reduction through oxyresveratrol-liposome encapsulation technology.
Case 2: Metabolic Syndrome Supplement
EU nutraceutical company reported 23% triglyceride reduction in clinical trials using 150mg oxyresveratrol/day formulation.
5. Verified Client Implementations
Client A: Topical Analgesic Manufacturer
• Requirement: Non-steroidal anti-inflammatory solution
• Solution: 1.8% oxyresveratrol gel formulation
• Outcome: 40% pain reduction vs placebo in osteoarthritis patients
Client B: Hair Care Formulator
• Challenge: UV-induced hair protein loss
• Implementation: 0.75% shampoo additive
• Result: 62% reduction in keratin degradation
6. Request Custom Formulation
Contact our technical team for formulation support:
Email: info@vivalr.com
Tel: (86) 15866781826
Technical Support Includes:
• Stability testing protocols
• Bioavailability enhancement solutions
• Regulatory compliance guidance



评论
目前还没有评论。